PharmiWeb

Niagen Bioscience Announces Participation in Upcoming Investor Conferences

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior leadership will ...
PharmiWeb

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...
PharmiWeb

Actio Biosciences Announces Initiation of KYRON Phase 1b/2 Trial of ABS-1230 for the Treatment of KCNT1-Related Epilepsy and Acceptance into FDA’s Rare Disease E…

Actio launches dedicated patient resource to support families seeking information about the KYRON clinical trial at ...
PharmiWebOpinion

EU Regulators Say Charlotte's Web Hemp CBD Safety "Cannot Be Established" - So Why Is It Entering Medicare?

"As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, ...
PharmiWeb

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

VANCOUVER, BC / ACCESS Newswire / May 8, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that Nucro-Technics Inc.
PharmiWeb

Monthly Letter April - Increased Activity and Growing Implementations

April was characterized by a high level of activity across several areas. We continue to see strong interest in Dosell, both ...
PharmiWeb

Assertio and Garda Mutually Agree to Delay Launch of Tender Offer

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the ...
PharmiWeb

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

Zacks increases 2026 revenue estimate to $103.2 million, up from $98.6 million in its prior January 2026 reportEPS outlook upgraded: Zacks now expects Cosmos Health to cross into positive EPS ...
PharmiWeb

Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ...
Opinion
PharmiWebOpinion

Experts Warn GOP: Don't Side With Hospital Lobby Over Trump 340B Reforms

WASHINGTON, D.C. / ACCESS Newswire / May 8, 2026 / The Hospital Accountability Project convened a roundtable of leading health policy experts this week to examine abuse in the federal 340B Drug ...
Opinion
PharmiWebOpinion

Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders

Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., Ltd. (TSE: 4527, “Rohto”), as a follow-up to its ongoing campaign, “Awakening ...
PharmiWeb

Black Book Nurses Week Survey: Payer Delays Are Reaching the Bedside Before Hospital C-Suite Sees the Damage

Third report in Black Book's five-month Nurses Week research series warns that prior authorization, denials, formulary barriers, and opaque payer decisions are creating hidden nursing workload, ...